Preferred Stock Channel
Quotes delayed 20 minutes

Email EnvelopeFree DHR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.26 out of 4)
48th percentile
(ranked lower than approx. 52% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com
www.valueforum.com/7/

Slideshow Preferred Stock Offerings

By Preferred Stock Channel Staff, updated Thursday, March 28, 8:18 PM

Slide #169. Danaher Corporation Preferred Stock Offering

Company: Danaher Corporation (NYSE:DHR)
Date announced: 2/25/2019
Shares Offered: 1,500,000
Date of Pricing: 2/26/2019
Price Per Share: $1,000.00
Preferred Stock Offering Details: Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has commenced concurrent offerings of $1.35 billion of shares of common stock and $1.35 billion of shares of Series A Mandatory Convertible Preferred Stock, subject to market and other conditions (the offerings). Danaher expects to grant the underwriters separate 30-day options to purchase up to an additional $135 million of shares of common stock, and up to an additional $135 million of shares of mandatory convertible preferred stock. -updated 2/26- Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced concurrent offerings of 11,000,000 shares of common stock at a price to the public of $123.00 per share and 1,500,000 shares of 4.75% Series A Mandatory Convertible Preferred Stock at a price to the public of $1,000 per share (the offerings). The underwriters have separate 30-day options to purchase up to an additional 1,100,000 shares of common stock, and up to an additional 150,000 shares of mandatory convertible preferred stock. The offerings are scheduled to be completed on March 1, 2019, subject to customary closing conditions.

Danaher designs, manufactures and markets medical, industrial and commercial products and services. Co.'s segments are: Biotechnology, which includes the bioprocessing and discovery and medical businesses and provides tools, consumables and services; Life Sciences, which provides instruments and consumables to understand the causes of disease, identify new therapies, and test and manufacture new drugs, vaccines and gene editing technologies; Diagnostics, which provides clinical instruments, reagents, consumables, software and services; and Environmental and Applied Solutions, which provides products and services that help protect resources and keep global food and water supplies safe.

Preferreds: DHR.PRA, DHR.PRB


Open the DHR Page at Preferred Stock Channel »

Name:  Danaher Corp
Website:  www.danaher.com
Sector:  Biotechnology
Number of ETFs Holding DHR:  99 (see which ones)
Total Market Value Held by ETFs:  $19,068,838,457.57
Total Market Capitalization:  $183,786,000,000
% of Market Cap. Held by ETFs:  10.38%
 

Open the DHR Page at Preferred Stock Channel (in a new window) »

Top Ten Highest Yielding Preferred Stocks
Feel-Good Income: Socially Responsible Preferreds
Dividend Channel's 25 S.A.F.E. Dividend Stocks
Increasing Payments For Decades

Safer than S.A.F.E: Preferreds of Dividend Channel's
S.A.F.E. Dividend Stocks

Recent Preferred Stock Offerings
Preferred Stocks of Dow Components
Preferred Stocks of S&P 500 Components
Preferred Stocks By Industry
Preferred Stocks Where Insiders Are Buying The Common
High Yield Preferred Stocks
Preferreds Trading At Premiums To Liquidation Preference
Preferreds Trading At Discounts To Liquidation Preference
The Top 10 DividendRank'ed U.S. Stocks
The Top 10 DividendRank'ed Canadian Stocks
Top 25 Broker Analyst Picks of the S&P 500
Stock market game

Preferred Stock Offerings - Slide 169 of 619 | www.PreferredStockChannel.com | Copyright © 2011 - 2024, All Rights Reserved

Nothing in Preferred Stock Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Preferred Stock Channel; Meet Our Editorial Staff.